Precigen, Inc.
General ticker "PGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
Precigen, Inc. follows the US Stock Market performance with the rate: 48.0%.
Estimated limits based on current volatility of 2.5%: low 6.82$, high 7.17$
Factors to consider:
- Total employees count: 160 (+21.2%) as of 2025
- Countries other than US accounted for 0.0% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Regulatory and compliance, Inability to raise capital, Inability to commercialize, Labor/talent shortage/retention, Supply chain disruptions
- Current price 20.8% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.37$, 5.80$]
- 2026-12-31 to 2027-12-31 estimated range: [1.91$, 4.76$]
Financial Metrics affecting the PGEN estimates:
- Positive: with PPE of -3.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.80 <= 0.28
- Negative: negative Net income
- Negative: Inventory ratio change, % of 61.39 > 0.79
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PGEN quotes
Long-term PGEN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6.22MM | $3.92MM | $9.68MM |
| Operating Expenses | $105.98MM | $138.95MM | $120.19MM |
| Operating Income | $-99.76MM | $-135.03MM | $-110.51MM |
| Non-Operating Income | $3.40MM | $7.00MM | $-140.13MM |
| Interest Expense | $0.47MM | $0.01MM | $3.87MM |
| R&D Expense | $48.61MM | $53.07MM | $41.33MM |
| Income(Loss) | $-96.36MM | $-128.03MM | $-250.64MM |
| Taxes | $-0.46MM | $-1.79MM | $0.00MM |
| Net Income(Loss)* | $-95.90MM | $-126.23MM | $-250.64MM |
| Stockholders Equity | $118.50MM | $38.51MM | $20.91MM |
| Inventory | $0.00MM | $0.00MM | $9.58MM |
| Assets | $151.04MM | $145.27MM | $155.50MM |
| Operating Cash Flow | $-66.93MM | $-68.17MM | $-87.83MM |
| Capital expenditure | $1.54MM | $8.58MM | $2.00MM |
| Investing Cash Flow | $-3.09MM | $-20.71MM | $-1.53MM |
| Financing Cash Flow | $29.59MM | $110.58MM | $90.05MM |
| Earnings Per Share** | $-0.39 | $-0.47 | $-0.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.